Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.
暂无分享,去创建一个
E. Traer | D. Pollyea | G. Mannis | Edna Cheung | T. Zhang | B. Jonas | V. Khanna | S. Liu | T. Azenkot | Kimberly Lau | Jason Gilbert